Identification of Leishmania donovani inhibitors from pathogen box compounds of Medicine for Malaria Venture
M. Tadele, S. M. Abay, E. Makonnen, A. Hailu
This study screens 400 compounds from the MMV Pathogen Box against Leishmania donovani and identifies 9 compounds with potent anti-promastigote and anti-amastigote activity, including two lead compounds with potential for combination therapy.
bioRxiv · Jul 26, 2019Pharmacology & Toxicology